These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1495742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y, Imai S, Shiraishi T, Tsubono M, Morimoto H, Tseng CC, Tobe T.
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [Abstract] [Full Text] [Related]

  • 10. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
    Akamatsu K, Endo K, Matsumoto T, Morikawa K, Koizumi M, Koizumi K, Mitsui H.
    Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
    [Abstract] [Full Text] [Related]

  • 11. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
    Morikawa K, Matsumoto T, Matsuoka Y, Koizumi K.
    Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
    [Abstract] [Full Text] [Related]

  • 12. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T, Morikage T, Sugimoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N.
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [Abstract] [Full Text] [Related]

  • 13. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
    Fujiwara Y, Nakamura M, Yokoo S.
    Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1.
    Ma J, Maliepaard M, Kolker HJ, Verweij J, Schellens JH.
    Cancer Chemother Pharmacol; 1998 Jun; 41(3):186-92. PubMed ID: 9443634
    [Abstract] [Full Text] [Related]

  • 17. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
    Akamatsu K, Endo K, Matsumoto T, Kamisango K, Morikawa K, Koizumi M, Koizumi K.
    Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
    [Abstract] [Full Text] [Related]

  • 18. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K, Endo K, Tsunenari T, Matsumoto T, Kaiho S, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [Abstract] [Full Text] [Related]

  • 19. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

  • 20. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
    Kikuchi Y, Iwano I, Miyauchi M, Kita T, Sugita M, Tenjin Y, Nagata I.
    Jpn J Cancer Res; 1990 Sep; 81(6-7):701-6. PubMed ID: 2119370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.